Morgan Keegan is out with its report today on RadNet RDNT, raising its PT from $4.30 to $5.15.
In a note to clients, Morgan Keegan writes, "We are modestly lowering our 2011 adjusted EBITDA estimate for RadNet from $118 million to $115 million and our 2012 estimate from $126 million to $124 million. However, we are raising our price target from $4.30 to $5.15 based on a multiple of 6.5x EV/EBITDAR."
Morgan Keegan maintains Outperform on RDNT.
At the time of posting, shares of RDNT were trading at $4.37, down 0.68% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care FacilitiesMorgan KeeganRadNet
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in